Skip to main content
InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
0.852
-0.047 (-5.22%)
At close: Apr 28, 2026, 4:00 PM EDT
0.867
+0.015 (1.73%)
After-hours: Apr 28, 2026, 4:10 PM EDT

InterCure Revenue

InterCure had revenue of 130.01M ILS in the half year ending June 30, 2025, a decrease of -37.68%. This brings the company's revenue in the last twelve months to 243.12M, down -10.84% year-over-year. In the year 2024, InterCure had annual revenue of 238.85M, down -32.82%.

Revenue (ttm)
243.12M ILS
Revenue Growth
-10.84%
P/S Ratio
0.70
Revenue / Employee
759,759 ILS
Employees
320
Market Cap
50.25M USD

Revenue Chart

* This company reports financials in ILS.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024238.85M-116.71M-32.82%
Dec 31, 2023355.55M-33.13M-8.52%
Dec 31, 2022388.68M169.01M76.93%
Dec 31, 2021219.68M154.64M237.78%
Dec 31, 202065.04M56.11M628.60%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Rockwell Medical 69.26M
Aytu BioPharma 62.64M
Cumberland Pharmaceuticals 44.52M
BGM Group 25.10M
Zhengye Biotechnology Holding 21.46M
SCYNEXIS 20.60M
China Pharma Holdings 4.14M
BioXcel Therapeutics 642.00K
Revenue Rankings

INCR News

More News